ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    17690799 [PUBMED-IDS]
Previous Study | Return to List | Next Study

Integrated Intervention for Substance Abusers With Depressive Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00018655
Recruitment Status : Terminated (PI has been contacted numerous times for an update, with no response. ORD requested a close out of this project. 10/2011)
First Posted : July 5, 2001
Last Update Posted : December 10, 2014
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development ( US Department of Veterans Affairs )

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications.

Condition or disease Intervention/treatment Phase
Substance-Related Disorders Depressive Disorder Behavioral: Twelve Step Facilitation Behavioral: Integrated Cognitive Behavioral Treatment Phase 2

Detailed Description:
This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications. Follow-up assessments were conducted at quarterly intervals for one year following treatment.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 276 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Integrated Intervention for Substance Abusers With Depressive Disorders
Study Start Date : April 2000
Actual Primary Completion Date : September 2009
Actual Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Arm 1
Twelve Step Facilitation
 Behavioral: Twelve Step Facilitation
Twelve Step Facilitation Therapy involves focusing on topics from 12-Step programs which support sobriety goals and personal growth.
Experimental: Arm 2
Integrated Cognitive Behavioral Treatment
 Behavioral: Integrated Cognitive Behavioral Treatment
Integrated Cognitive Behavioral Treatment involves focusing on thoughts, activities, and interactions with people related to depressive symptoms and/or substance use.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Hamilton Depression Scale, Timeline Follow-back (substance measure) [ Time Frame: 18 months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Veterans age 18 and older with alcohol, cannabinol, and/or stimulant dependence and independent mood disorders will be included.

Exclusion Criteria:

Psychotic disorders

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018655


Locations
United States, California
VA San Diego Healthcare System, San Diego
San Diego, California, United States, 92161
Sponsors and Collaborators
US Department of Veterans Affairs
Investigators
Principal Investigator: Susan Tate, PhD VA San Diego Healthcare System, San Diego
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Other Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: US Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018655     History of Changes
Other Study ID Numbers: MHBS-041-99S
First Posted: July 5, 2001    Key Record Dates
Last Update Posted: December 10, 2014
Last Verified: December 2014

Keywords provided by VA Office of Research and Development ( US Department of Veterans Affairs ):
Mood Disorders
Substance-Related Disorders

Additional relevant MeSH terms:
Disease
Depressive Disorder
Depression
Substance-Related Disorders
Pathologic Processes
 Mood Disorders
Mental Disorders
Behavioral Symptoms
Chemically-Induced Disorders